Feat; Women in pharma: Empowering success -- AI has arrived -- Harnessing good design
An in-depth look at the myriad ways artificial intelligence is changing the industry
For successful clinical trials today, it’s necessary to go global. But challenges still abound
A new report looks at the effectiveness of dedicated UK twitter accounts for pharma companies
The former president of AstraZeneca UK and the ABPI has given up big pharma to join biotech Redx. We speak to her about what prompted the change, how she thinks British life science will fare in the coming years, and how the UK can help smaller companies like Redx to thrive
Marketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside Communications Team of the Year and the all-new Sales Awards.
19th October 2018
International Clinical Researcher of the Year is celebrating its 20th anniversary in 2019. If ever there was a time to stand out against the competition and be remembered, it's now!
19th October 2018
There are only two weeks to go until the 31 October deadline, don't miss it - get your entry in now!Highlighting this important area of work within the pharmaceutical industry, the new Medical & Scientific Excellence Awards are designed to recognise the outstanding achievements of medical and scientific professionals.
19th October 2018
A pivotal Phase III trial investigating a combination of MSD’s anti-PD-1 therapy Keytruda and Pfizer’s tyrosine kinase inhibitor Inlyta has shown a significant benefit on both overall (OS) and progression-free survival (PFS) in patients with kidney cancer.
19th October 2018
Shire’s prucalopride has taken a giant leap towards approval after winning the support of an FDA advisory committee for chronic idiopathic constipation.
19th October 2018
How pharma companies are starting to lead the change in workplace mental health
What the proposed changes to the National Institutes of Health Recombinant DNA Advisory Committee mean for patients and drug developers
Evolving the pharma value proposition
Aaron Hudson from SCIEX provides insight on the potential impact of genetic and non-genetic biomarkers for precision medicine
Steve How of Wilmington Healthcare explains how health and social care groups are uniting within ‘neighbourhoods’ and what pharma can do to support them
How harnessing design can help pharma connect with patients and customers and save lives
AstraZeneca's vice president and head, IMED Respiratory on the importance of a supportive network and the challenges of a work-life balance
Medidata's chief human resources officer on bringing women into company boards and the importance of a good mentor relationship
An in-depth look at the myriad ways artificial intelligence is changing the industry
What a new commercial model to engage with HCPs should look like
BMS’ director, hub unit manager Regional Clinical Operations on the need for excellence in clinical research
At just 20 years old Kirsty Mills received a shock diagnosis of liver cirrhosis, following diagnoses of autoimmune hepatitis and lupus. She talks about her experiences with these conditions, and is keen to challenge the misconception that liver disease is all too often associated only with drug and alcohol abuse
By making use of Flash Organisations, the industry could accelerate and magnify its operational success, and consequently stimulate the growth of business
How precision oncology is helping to address the dichotomy of patient scarcity versus an abundance of disparate data
It’s an exciting time to be working in the industry; with this comes new opportunities to collaborate and drive innovation
Inceptua’s Edoardo Madussi shares his insights on how to overcome the challenges of multi-country clinical trials
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
